Cardiovascular Report Summer 2009
Articles in this Issue
Cardiac Stem Cells
As part of a clinical trial, Bill Beatty received an infusion of stem cells derived from his own heart tissue, making him the second patient in the world to undergo this procedure.
If you asked any of the hundreds of clinicians and researchers who’ve participated in the Johns Hopkins CTA Practicum what was most memorable, you’d likely get a common response: intense and impassioned.
Pacemakers and implantable cardioverter defibrillators have come a long way in the past two decades, yet the debate continues regarding the safety of performing MRI in patients who have the devices.
Endovascular repair for aortic aneurysms is performed routinely, but these repairs are still risky.
For patients who survive a myocardial infarction, the aftermath is often left ventricular remodeling causing dilation of LV, congestive heart failure—and poor quality of life. One alternative to a heart transplant that cardiac surgeon John Conte has found effective in carefully selected patients is surgical ventricular reconstruction.
Mary Ann Ayd, managing editor